UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Unbranched rod-like RNA is required for RNA editing of hepatitis delta virus genotype 2 and genotype 4

Virus research, 2023-12, Vol.338, p.199239-199239, Article 199239

2023

Volltextzugriff (PDF)

Higher HBeAg‐reversion virological relapse and lower sustained remission after treatment cessation in tenofovir‐treated HBeAg‐positive patients

Journal of medical virology, 2023-11, Vol.95 (11), p.e29213-n/a

2023

Volltextzugriff (PDF)

Off‐therapy durability of response to entecavir therapy in hepatitis B e antigen‐negative chronic hepatitis B patients

Hepatology (Baltimore, Md.), 2013-12, Vol.58 (6), p.1888-1896

2013

Volltextzugriff (PDF)

Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype

Cancer science, 2024-02, Vol.115 (2), p.564-574

2024

Volltextzugriff (PDF)

The symptoms of autism including social communication deficits and repetitive and restricted behaviors are associated with different emotional and behavioral problems

Scientific reports, 2020-11, Vol.10 (1), p.20509-20509, Article 20509

2020

Volltextzugriff (PDF)

The efficacy and safety of elbasvir/grazoprevir treatment in HCV genotype 1 patients in Taiwan

Journal of medical virology, 2020-02, Vol.92 (2), p.219-226

2020

Volltextzugriff (PDF)

Maintaining complete virological suppression by reduced doses of nucleos(t)ide analogue in patients with chronic hepatitis B

Journal of medical virology, 2019-07, Vol.91 (7), p.1360-1363

2019

Volltextzugriff (PDF)

Drug‐induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in Taiwan

Liver international, 2021-11, Vol.41 (11), p.2671-2680

2021

Volltextzugriff (PDF)

Reduction of ACE2 Serum Concentrations by Telbivudine in Chronic Hepatitis B Patients

Current molecular medicine, 2023-01, Vol.23 (5), p.420-424

2023

Volltextzugriff (PDF)

Impact of hepatic steatosis on treatment response in nuclesos(t)ide analogue-treated HBeAg-positive chronic hepatitis B: a retrospective study

BMC gastroenterology, 2020-05, Vol.20 (1), p.146-146, Article 146

2020

Volltextzugriff (PDF)

The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies

BMC cancer, 2020-10, Vol.20 (1), p.1018-12, Article 1018

2020

Volltextzugriff (PDF)

Advanced Liver Fibrosis Is Associated with Necroinflammatory Grade but Not Hepatic Steatosis in Chronic Hepatitis B Patients

Digestive diseases and sciences, 2021-12, Vol.66 (12), p.4492-4500

2021

Volltextzugriff (PDF)

Investigating the Genetic Diversity of Hepatitis Delta Virus in Hepatocellular Carcinoma (HCC): Impact on Viral Evolution and Oncogenesis in HCC

Viruses, 2024-05, Vol.16 (6), p.817

2024

Volltextzugriff (PDF)

Identification of postoperative prognostic microRNA predictors in hepatocellular carcinoma

PloS one, 2012-05, Vol.7 (5), p.e37188-e37188

2012

Volltextzugriff (PDF)

Hepatitis C micro-elimination through the retrieval strategy of patients lost to follow-up

BMC gastroenterology, 2023-02, Vol.23 (1), p.40-40, Article 40

2023

Volltextzugriff (PDF)

Long-term renal function alterations in hepatitis C patients with SVRs: Impacts of therapies and mixed cryoglobulinemia

Journal of infection and public health, 2024-03, Vol.17 (3), p.486-494

2024

Volltextzugriff (PDF)

Performance of commercially available anti-HDV enzyme-linked immunosorbent assays in Taiwan

Virology journal, 2020-06, Vol.17 (1), p.76-76, Article 76

2020

Volltextzugriff (PDF)

Emergence of hepatitis B virus S gene mutants in patients experiencing hepatitis B surface antigen seroconversion after peginterferon therapy

Hepatology (Baltimore, Md.), 2011-07, Vol.54 (1), p.101-108

2011

Volltextzugriff (PDF)

Preventing viral relapse with prophylactic tenofovir in hepatitis B carriers receiving chemotherapy: a phase IV randomized study in Taiwan

Hepatology international, 2024-04, Vol.18 (2), p.449-460

2024

Volltextzugriff (PDF)

Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B

Hepatology international, 2020-12, Vol.14 (6), p.997-1008

2020

Volltextzugriff (PDF)

Early hepatitis B virus DNA reduction in hepatitis B e antigen–positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir

Hepatology (Baltimore, Md.), 2009-01, Vol.49 (1), p.72-79

2009

Volltextzugriff (PDF)

Decreasing seroprevalence of anti‐hepatitis D virus antibodies in the antiviral era with inverse association with hepatitis B virus DNA, Taiwan, 2006 to 2019

Journal of medical virology, 2020-01, Vol.92 (1), p.124-127

2020

Volltextzugriff (PDF)

Structural Pattern Differences in Unbranched Rod-Like RNA of Hepatitis Delta Virus Affect RNA Editing

Viruses, 2019-10, Vol.11 (10), p.934

2019

Volltextzugriff (PDF)

A Circulating MicroRNA Signature Capable of Assessing the Risk of Hepatocellular Carcinoma in Cirrhotic Patients

Scientific reports, 2017-03, Vol.7 (1), p.523-523, Article 523

2017

Volltextzugriff (PDF)

Multi-Omics Analyses Identify Signatures in Patients with Liver Cirrhosis and Hepatocellular Carcinoma

Cancers, 2022-12, Vol.15 (1), p.210

2022

Volltextzugriff (PDF)

1 – 25 von 370

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(320)
Mit Volltextzugriff
(331)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(370)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(259)
Life Sciences & Biomedicine
(190)
Humans
(131)
Female
(86)
Male
(73)
Middle Aged
(69)
Technology
(46)
Adult
(45)
Physical Sciences
(42)
Hepatocellular Carcinoma
(40)
Aged
(39)
Oncology
(39)
Hepatitis B
(36)
Patients
(36)
Gastroenterology & Hepatology
(30)
Animals
(27)
Hepatitis
(27)
Hepatitis B Virus
(25)
Liver Cancer
(25)
Science & Technology - Other Topics
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Unbranched rod-like RNA is required for RNA editing of hepatitis delta virus genotype 2 and genotype 4

Higher HBeAg‐reversion virological relapse and lower sustained remission after treatment cessation in tenofovir‐treated HBeAg‐positive patients

Off‐therapy durability of response to entecavir therapy in hepatitis B e antigen‐negative chronic hepatitis B patients

Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype

The symptoms of autism including social communication deficits and repetitive and restricted behaviors are associated with different emotional and behavioral problems

The efficacy and safety of elbasvir/grazoprevir treatment in HCV genotype 1 patients in Taiwan

Maintaining complete virological suppression by reduced doses of nucleos(t)ide analogue in patients with chronic hepatitis B

Drug‐induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in Taiwan

Reduction of ACE2 Serum Concentrations by Telbivudine in Chronic Hepatitis B Patients

Impact of hepatic steatosis on treatment response in nuclesos(t)ide analogue-treated HBeAg-positive chronic hepatitis B: a retrospective study

The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies

Advanced Liver Fibrosis Is Associated with Necroinflammatory Grade but Not Hepatic Steatosis in Chronic Hepatitis B Patients

Investigating the Genetic Diversity of Hepatitis Delta Virus in Hepatocellular Carcinoma (HCC): Impact on Viral Evolution and Oncogenesis in HCC

Identification of postoperative prognostic microRNA predictors in hepatocellular carcinoma

Hepatitis C micro-elimination through the retrieval strategy of patients lost to follow-up

Long-term renal function alterations in hepatitis C patients with SVRs: Impacts of therapies and mixed cryoglobulinemia

Performance of commercially available anti-HDV enzyme-linked immunosorbent assays in Taiwan

Emergence of hepatitis B virus S gene mutants in patients experiencing hepatitis B surface antigen seroconversion after peginterferon therapy

Preventing viral relapse with prophylactic tenofovir in hepatitis B carriers receiving chemotherapy: a phase IV randomized study in Taiwan

Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B

Early hepatitis B virus DNA reduction in hepatitis B e antigen–positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir

Decreasing seroprevalence of anti‐hepatitis D virus antibodies in the antiviral era with inverse association with hepatitis B virus DNA, Taiwan, 2006 to 2019

Structural Pattern Differences in Unbranched Rod-Like RNA of Hepatitis Delta Virus Affect RNA Editing

A Circulating MicroRNA Signature Capable of Assessing the Risk of Hepatocellular Carcinoma in Cirrhotic Patients

Multi-Omics Analyses Identify Signatures in Patients with Liver Cirrhosis and Hepatocellular Carcinoma

Suchergebnisse filtern